PLUS: A significant shift in Xero's US strategy; Drury responds.
Wed, 01 Apr 2015
Macquarie has downgraded Xero from neutral to underperform but increased its 12-month target price from $19.00 to $20.25.
Shares [NZX:XRO], which shook off a long slump in the mid-teens after the company's $147 million capital raise in February, were down 1.66 % to $23.70 in early afternoon
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).